MiMedx reports EpiFix allograft positive results
06:08 EDT 8 Aug 2012 | Medical Business Review
MiMedx Group has reported positive results from a study of its EpiFix, a dehydrated human amniotic membrane allograft, designed as a treatment for diabetic neurovascular foot ulcers.
Original Article: MiMedx reports EpiFix allograft positive results
More From BioPortfolio on "MiMedx reports EpiFix allograft positive results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
